Thistle and Reduced Low-Density Lipoprotein Level

Across 3 studies, all reported statistically significant beneficial effects of thistle (silymarin/silibinin) on reducing low-density lipoprotein (LDL) cholesterol. Effect sizes were small in two studies and moderate in one, with the largest and highest-quality study (a meta-analysis of 2,283 patients) showing a small but significant reduction (SMD: -0.25). No consistent dose, form, or duration data were available across studies.

• Studied populations: clinical patients (primarily nonalcoholic fatty liver disease in the meta-analysis); diabetes-related populations in one review

Caveats: Evidence base is small (only 3 studies) — conclusions should be considered preliminary. Available evidence is overwhelmingly positive — clinical literature in this area is subject to publication bias (null-result studies are less likely to be published or indexed). No dose, form, or duration data were consistently reported, limiting practical application. The largest study was a meta-analysis on NAFLD patients, so generalizability to other populations is uncertain.